Exyte on course for record year with significant sales growth and strong order intake
Financial results for the first nine months of 2018
- Record sales of € 2.6 billion in the first nine months (+81% year-on-year)
- Significant improvement in earnings: adj. EBIT increases to € 111 million, more than doubling year-on-year
- Order intake of € 3.5 billion (+49% year-on-year) boosts order backlog to € 3.0 billion
- Outlook for the full reporting year 2018 confirmed: Order intake > € 4 billion, sales € 3.5 billion and adj. EBIT > € 160 million
Stuttgart, 14 December 2018 - Exyte AG ("Exyte"), a global leader in the design, engineering and construction of high-technology facilities, generated sales of € 2.6 billion in the first nine months of 2018. This corresponds to a growth of +81% compared to the same period of the previous year. Exyte has thus already generated more sales in the first three quarters of 2018 than in the entire reporting year 2017.
In the first nine months of 2018, adjusted EBIT improved disproportionally to sales and rose to € 111 million, more than twice the previous year's figure (€ 51 million). The adjusted EBIT margin increased to 4.3% in the first nine months (previous year: 3.6%).
"Exyte clearly remains on a path for ongoing growth. With our exceptional performance in the past months, we are undoubtedly heading towards a record year," said Dr. Wolfgang Büchele, CEO of Exyte. "Exyte's key growth driver remains our Advanced Technology Facilities (ATF) segment, in which we serve customers in the semiconductor industry. As a result of digitalization and rapidly increasing data volumes, global demand for our solutions is steadily increasing and is positively impacting our business, regardless of fluctuations in semiconductor selling prices.”
Record order intake and order backlog
With the company increasing its order intake by an average of 19% per year since 2015, Exyte achieved a total order intake of € 3.5 billion in the first nine months of 2018, corresponding to a year-on-year increase of 49%. The sustained growth of its served available markets and Exyte's strategic focus on the three core business segments - ATF, Life Science and Chemicals (LSC) and Data Center (DTC) - positively impacted the company’s order intake. With an order backlog of € 3.0 billion (+40% year-on-year), the order books remain well filled.
"The fact that we were able to significantly increase our order intake and sales as well as important performance indicators such as the adjusted EBIT shows the great potential of our company," said Exyte CFO Wolfgang Homey. "Thanks to our outstanding positioning in global growth markets, our good customer relations and the strategic realignment of our company, we are convinced that we will continue to grow profitably well beyond 2018.”
Exyte confirms its outlook for the 2018 financial year and expects to achieve record sales of around € 3.5 billion. For the entire reporting year 2018, the company anticipates a significant year-on-year increase in an adjusted EBIT to over € 160 million. Order intake is also expected to reach a new record level of over € 4 billion.
A detailed report is available at www.ir.exyte.net.
Exyte is a global leader in design, engineering and construction delivering high-tech facilities, plants and factories. With a history of more than 100 years, we have developed a special expertise in controlled and regulated environments. We serve the most technically demanding clients in growth markets such as semiconductors, life sciences, and data center across the full spectrum of services from consulting and design to managing turnkey solutions. Operating in more than 20 countries, Exyte is uniquely positioned to support clients locally and globally. In 2017, Exyte generated sales of 2.4 billion euros, up from 2.1 billion euros in 2016 on a like-for-like basis, with over 4,800 highly experienced and motivated employees (by the end of the year 2017). Exyte emerged from a re-grouping of the M+W Group in 2018. Exyte is a member of the Stumpf Group. For further information about the company please see our website: www.exyte.net